Sassi Claudia, Stanzani Marta, Lewis Russell E, Facchini Giancarlo, Bazzocchi Alberto, Cavo Michele, Battista Giuseppe
1 Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Division of Radiology, S.Orsola-Malpighi Hospital, University of Bologna , Bologna , Italy.
2 Department of Hematology and Oncology, Institute of Hematology "L. e A. Seragnoli", S.Orsola-Malpighi Hospital, University of Bologna , Bologna , Italy.
Br J Radiol. 2018 Feb;91(1083):20170220. doi: 10.1259/bjr.20170220. Epub 2018 Jan 10.
The hypodense sign (HyS) on CT imaging is highly suggestive of pulmonary invasive mould disease (IMD) in patients with haematological malignancies, but its diagnostic utility has not been systematically evaluated on contrast-enhanced CT. The objective of this study was to compare the diagnostic performance of the HyS to other common CT findings in a cohort of haematology patients with proven, probable or possible IMD based on European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria.
We analysed the diagnostic performance of the HyS to other common CT signs among 127 neutropenic patients with haematological malignancies submitted to both non-contrast-enhanced and contrast-enhanced CT scans of the lungs, including CT pulmonary angiography.
The HyS was detected in 15.7% of patients imaged without contrast, and 44.1% after contrast administration. A contrast-aided HyS was detected in 86.6, 78.0 and 15.5% of patients with European Organization for Research and Treatment of Cancer/Mycoses Study Group proven, probable and possible IMD, respectively. When analysed per clinical diagnosis (proven, probable and highly possible IMD-i.e. no alternative diagnosis to mould disease reached), the contrast-enhanced HyS was as sensitive as the halo sign but significantly more specific [halo sign 0.56, 95% CI (0.39-0.71) vs HyS 0.98, 95% CI (0.87-1.00)]. Only the vessel occlusion sign was more sensitive [0.97, 95% CI (0.91-0.99)] and specific [0.97, 95% CI (0.86-0.99)] than the HyS for IMD diagnosis.
The high specificity of the HyS strongly supports the diagnosis of pulmonary IMD in neutropenic patients, and is highly suggestive breakthrough fungal disease in patients on mould-active antifungal prophylaxis. Advances in knowledge: This is the first systematic analysis of the hypodense sign on contrast-enhanced CT; the sign can support the diagnosis of IMD when other CT signs are uncertain.
CT成像上的低密度征(HyS)高度提示血液系统恶性肿瘤患者发生肺侵袭性霉菌病(IMD),但其在增强CT上的诊断效用尚未得到系统评估。本研究的目的是在一组根据欧洲癌症研究与治疗组织/真菌病研究组标准确诊、很可能或可能患有IMD的血液学患者中,比较HyS与其他常见CT表现的诊断性能。
我们分析了127例血液系统恶性肿瘤中性粒细胞减少患者的HyS及其他常见CT征象的诊断性能,这些患者均接受了肺部非增强和增强CT扫描,包括CT肺动脉造影。
在未增强成像的患者中,15.7%检测到HyS,增强后为44.1%。在欧洲癌症研究与治疗组织/真菌病研究组确诊、很可能和可能患有IMD的患者中,分别有86.6%、78.0%和15.5%检测到增强辅助HyS。按临床诊断(确诊、很可能和极有可能患有IMD,即除霉菌病外无其他诊断)分析时,增强后的HyS与晕征敏感性相同,但特异性显著更高[晕征0.56,95%CI(0.39 - 0.71)vs HyS 0.98,95%CI(0.87 - 1.00)]。仅血管闭塞征在IMD诊断方面比HyS更敏感[0.97,95%CI(0.91 - 0.99)]和更具特异性[0.97,95%CI(0.86 - 0.99)]。
HyS的高特异性有力地支持了中性粒细胞减少患者肺IMD的诊断,对于接受抗霉菌活性抗真菌预防的患者高度提示突破性真菌病。知识进展:这是对增强CT上低密度征的首次系统分析;当其他CT征象不确定时,该征象可支持IMD的诊断。